Could a finger prick replace blood draws for prostate cancer drug monitoring?
NCT ID NCT07344363
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether dried blood spots from a finger prick can reliably measure levels of common prostate cancer drugs. Researchers will compare results from the finger-prick method with standard blood tests in 100 patients. If the new method works, it could make drug monitoring easier and more convenient for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
abiraterone, apalutamide, darolutamide, enzalutamide
What this could lead to
If successful, this could make it easier and less invasive to monitor drug levels in prostate cancer patients, potentially improving treatment management.
What could go wrong
This is an early-stage validation study, not a treatment trial. The new method may not prove reliable enough to replace standard blood tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
RECRUITINGAviano, Pordenone, 33081, Italy
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact